Enlarge (credit: Getty | Chip Somodevilla)
The Food and Drug Administration is expected to authorize booster doses of the Pfizer-BioNTech COVID-19 vaccine for all adults as early as Thursday, agency insiders told The New York Times Tuesday.
The reported timeline is remarkably fast-paced for the regulatory agency and comes as members of the Biden administration continue to suggest widespread boosting is necessary to bring the COVID-19 pandemic under control.
"I believe... that when we look back on this, we will see that boosters are likely a very critical part of the immunization regimen and not a bonus or a luxury," top infectious disease expert Anthony Fauci told Reuters on Tuesday.
Read 11 remaining paragraphs | Comments
source https://arstechnica.com/?p=1813932
Tags:
Technology Update